Table 5. Characteristics of the 190 trials registered with one of the 72 drugs of the ReDO_DB tested in clinical trials.
| N | % | ||
|---|---|---|---|
| Drug with more than 10 trials | |||
| Acetylsalicylic acid | 27 | 14 | |
| Celecoxib | 12 | 6 | |
| Cholecalciferol | 12 | 6 | |
| Metformin | 17 | 9 | |
| Olanzapine | 10 | 5 | |
| Zoledronic Acid | 20 | 11 | |
| Cancer Type | |||
| Gastrointestinal | 53 | 28 | |
| Breast | 38 | 20 | |
| Hematologic | 23 | 12 | |
| Lung | 14 | 7 | |
| Gynaecologic | 11 | 6 | |
| Brain and CNS | 10 | 5 | |
| Other | 24 | 13 | |
| Paediatric | 12 | 6 | |
| Not specified | 23 | 12 | |
| Trial Location | |||
| Europe | 68 | 36 | |
| Asia | 61 | 32 | |
| North America | 48 | 25 | |
| Middle East | 11 | 6 | |
| Oceania | 7 | 4 | |
| South & Central America | 6 | 3 | |
| Africa | 5 | 3 | |
| Sponsor | |||
| University and/or hospital | 127 | 67 | |
| Research Institute, organisation, foundation or network | 53 | 28 | |
| Small- and medium-sized pharmaceutical companies | 6 | 3 | |
| Government | 3 | 2 | |
| Large pharmaceutical companies | 1 | 1 | |